Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
8.59
-0.20 (-2.28%)
At close: Oct 21, 2025, 4:00 PM EDT
8.60
+0.01 (0.12%)
After-hours: Oct 21, 2025, 7:59 PM EDT

Novavax Revenue

Novavax had revenue of $239.24M in the quarter ending June 30, 2025, a decrease of -42.42%. This brings the company's revenue in the last twelve months to $1.08B, up 9.22% year-over-year. In the year 2024, Novavax had annual revenue of $682.16M, down -30.65%.

Revenue (ttm)
$1.08B
Revenue Growth
+9.22%
P/S Ratio
1.28
Revenue / Employee
$1,133,107
Employees
952
Market Cap
1.40B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024682.16M-301.54M-30.65%
Dec 31, 2023983.71M-998.17M-50.36%
Dec 31, 20221.98B835.58M72.89%
Dec 31, 20211.15B670.69M141.02%
Dec 31, 2020475.60M456.94M2,448.48%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro